The company's average rating score is 2.22, and is based on 4 buy ratings, 3 hold ratings, and 2 sell ratings.Identify stocks that meet your criteria using seven unique stock screeners. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.The dividend payout ratio of Novartis is 38.36%.
Latest media releases and statements in the Novartis Newsroom. Enter Magazine.
View breaking news headlines for NVS stock from trusted media outlets at MarketBeat.
Novartis Stock Slips After Sales Miss Views On Coronavirus Impact ... Novartis News: auf dieser Seite finden Sie alle Novartis News und Nachrichten zur Novartis Aktie. Novartis trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVS." Novartis employs 103,914 workers across the globe.According to analysts' consensus price target of $108.00, Novartis has a potential upside of 27.9% from its current price of $84.41.Novartis has only been increasing its dividend for 1 years.Earnings for Novartis are expected to grow by 11.46% in the coming year, from $5.67 to $6.32 per share.NVS stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Scharf Investments LLC, Park National Corp OH, Trust Co. of Vermont, CIBC Asset Management Inc, Creative Planning, Thomasville National Bank, and Janney Montgomery Scott LLC.Based on earnings estimates, Novartis will have a dividend payout ratio of 31.80% next year. What's going on at Novartis (NYSE:NVS)?
Get short term trading ideas from the MarketBeat Idea Engine.
Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.You have already added five stocks to your watchlist. Novartis stock fell alongside its pharma peers Tuesday despite reiterating its 2020 outlook in the face of the coronavirus pandemic. Want to see which stocks are moving? The Swiss drug giant also topped first-quarter expectations.
Top institutional investors include Manning & Napier Group LLC (0.09%), Scharf Investments LLC (0.06%), Envestnet Asset Management Inc. (0.04%), First Trust Advisors LP (0.02%), Welch Group … European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing. See what's happening in the market right now with MarketBeat's real-time news feed. The company earns $11.73 billion in net income (profit) each year or $5.24 on an earnings per share basis. Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Top institutional shareholders include Manning & Napier Group LLC (0.09%), Scharf Investments LLC (0.06%), Raymond James & Associates (0.06%), Envestnet Asset Management Inc. (0.04%), First Trust Advisors LP (0.02%) and Douglas Lane & Associates LLC (0.02%).Novartis has a market capitalization of $193.19 billion and generates $47.50 billion in revenue each year.
View breaking news headlines for NVS stock from trusted media outlets at MarketBeat.
PEG Ratios above 1 indicate that a company could be overvalued.Only 10.80% of the stock of Novartis is held by institutions.The P/E ratio of Novartis is 26.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.15.Novartis has received a consensus rating of Hold. Export data to Excel for your own analysis.Receive a free world-class investing education from MarketBeat. Realtime quote and/or trade prices are not sourced from all markets.Novartis stock fell alongside its pharma peers Tuesday despite reiterating its 2020 outlook in the face of the coronavirus pandemic.Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities.
View which stocks are hot on social media with MarketBeat's trending stocks report.Shares of NVS can be purchased through any online brokerage account.
Novartis Aktie (NOVN) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen.